CellsBin Wins NCI SBIR Award to Advance Blood-Based Multiple Myeloma Test

CellsBin®, a biotechnology company pioneering Rare-Cell Biology™, announced that it has received a Direct-to-Phase II Small Business Innov...

October 29, 2026 | Thursday | News
Abbott Launches Next-Generation Oncodetect MRD Test Using Whole-Genome Sequencing

Powered by whole-genome sequencing and MAESTRO* technology, the next-generation Oncodetect test takes a distinct approach to MRD,...

October 28, 2026 | Wednesday | News
Made Scientific Partners with CARR Biosystems to Scale Cell Therapy Manufacturing

Made Scientific to integrate multiple UniFuge® single-use centrifugation systems across its Princeton, NJ, and East Norriton, PA, facilities to suppo...

October 28, 2026 | Wednesday | News
Kos Biotechnology Partners Invests in Golden Age Health to Expand Rare Disease Drug Access in Asia

Golden Age Health is co-founded and chaired by Michel Vounatsos, former Biogen CEO and Merck President Kos Biotechnology Partners ("Kos"), a global ...

October 28, 2026 | Wednesday | News
SystImmune and Bristol Myers Squibb’s Iza-Bren Extends Progression-Free Survival in Phase 3 Lung Cancer Trial

Late-breaking results to be presented in an oral presentation at ESMO 2026 PANKU-Lung01 is the first Phase 3 trial to evaluate a dual-targeting EGFRxHER...

October 27, 2026 | Tuesday | News
BioAgilytix Expands Global Bioanalytical Capabilities Through New 360biolabs Sydney Laboratory

BioAgilytix, a  global bioanalytical Contract Research Organization (CRO), announces the expansion of its  Australian laboratories through the op...

October 27, 2026 | Tuesday | News
Tango Therapeutics Reports 82% Response Rate for Vopimetostat Combination in Pancreatic Cancer

82% objective response rate, median progression-free survival (PFS) not yet reached, and 9-month PFS-rate of 88% in patients with 2L/3L pancreatic cancer t...

October 26, 2026 | Monday | News
Marengo Therapeutics Reports Phase 2 Invikafusp Alfa Responses Across Eight Cancer Types

Objective responses observed across eight distinct tumor types, including breast, colorectal, endometrial, gastroesophageal junction,...

October 26, 2026 | Monday | News
HanchorBio and Aston Sci Partner to Develop Combination Immunotherapies for Gastric and Breast Cancers

Strategic collaboration pairs HCB101 (macrophage CD47-SIRPα blockade) with Aston Sci's Phase 2 HER2-directed DNA vaccine (AST-301) to drive durable...

October 23, 2026 | Friday | News
Cognition Therapeutics Reaches FDA Agreement on Phase 3 Zervimesine Trial for Lewy Body Dementia

Cognition Therapeutics, Inc., (the Company or Cognition) (NASDAQ: CGTX), a clinical-stage company developing product candidates that treat neurodegenerativ...

October 23, 2026 | Friday | News
Lilly’s Omvoh Meets Primary Endpoint in Phase 3 Paediatric Ulcerative Colitis Trial

Building on Omvoh's approved use and durable efficacy in adults, Lilly plans to submit these data to global regulators to support a potential label expansi...

October 20, 2026 | Tuesday | News
FDA Approves Roche’s Enspryng for Adults with Thyroid Eye Disease

FDA approval based on Phase III SatraGO-1 and -2 studies, with SatraGO-2 demonstrating a significant reduction in eye bulging (proptosis) and improvement...

October 19, 2026 | Monday | News
Aignostics Launches HETA Clinical for Digital Pathology Workflows

Aignostics announced the launch of HETA Clinical, a new family of pan-cancer AI products spanning the pathology workflow from intake and evaluation to mole...

October 19, 2026 | Monday | News
Systech Launches ST33 and ST34 Carton Serialization Systems for Pharma Packaging

Systech, a global leader in pharmaceutical serialization and traceability solutions, has launched the ST33 Carton Serialization Station and ST34 Carton Ser...

October 19, 2026 | Monday | News

Survey Box

Poll of the Week

Which area of biopharmaceutical research excites you the most?

× Please select an option to participate in the poll.
Processing...
× You have successfully cast your vote.
 {{ optionDetail.option }}  {{ optionDetail.percentage }}%
 {{ optionDetail.percentage }}% Complete
More polls
Stay Connected

Sign up to our free newsletter and get the latest news sent direct to your inbox

© 2026 Biopharma Boardroom. All Rights Reserved.

Show

Forgot your password?

Show

Show

Lost your password? Please enter your email address. You will receive a link to create a new password.

Back to log-in

Close